Atara Biotherapeutics, Inc. (ATRA) Shareholders’ equity 2022–2025
Atara Biotherapeutics, Inc. (ATRA) shareholders’ equity at each fiscal year-end, per SEC filings.
-$38.5MFY2025 · since FY2022: $126.6M → -$38.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.5M | +60.4% |
| FY2024 | -$97.3M | -198.0% |
| FY2023 | $99.2M | -21.6% |
| FY2022 | $126.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice